FDA Inspection 1275744 — CGG Medical Inc

CGG Medical Inc — FEI 3027627539

The FDA completed an inspection of CGG Medical Inc on Jul 16, 2025 in Pensacola, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 16, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Pensacola, FL (United States)

Citations

IDCFRDescription
1233821 CFR 1271.180(b)Review and approval-responsible person
1241521 CFR 1271.260(e)Temperature limits

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.